Novel diagnostics measures clock gene expression for early detection of fetal alcohol spectrum disorder

​

Novel salivary diagnostic test to measure circadian clock gene expression in FASD children using saliva samples.


Invention Summary:

Alcohol drinking during pregnancy leads to fetal alcohol spectrum disorder (FASD) accounting for about 2-5% of children in North America. Early diagnosis of FASD is imperative to prevent brain damage in FASD patients. There is no specific diagnostic test available so far.

Rutgers researchers notably identified the core-clock genes expression in a rhythmic pattern in human saliva. The expression pattern is significantly altered in FASD children. Dysregulation of clock gene expression is implicated in a variety of childhood diseases, particularly neurodevelopmental disorders and metabolic conditions.  Hence, detection of clock gene abnormalities in biological fluids may provide an opportunity for early diagnosis of childhood diseases. Human saliva is a good source of DNA/RNA, protein, and metabolites, making it ideal to assess FASD. Thus, developing a non-invasive saliva-based diagnostic kit to measure clock gene expression is highly useful to reduce FASD-related morbidities and improve the quality of life of individuals with FASD.

Market Applications: 

  • Diagnostic kits for FASD or other childhood diseases. 
  • Prognostic risk assessment of children born to mothers who drink alcohol during pregnancy.
Advantages: 
  • Non-invasive detection method and ease of collecting samples 
  • Cost effective measurement
Publications: 
  • Das U, Thomas JD, Tarale P, Soja J, Inkelis S, Chambers C, Sarkar DK. Sci Rep. 2024 Aug 27;14(1):19886. 
Intellectual Property & Development Status: Provisional application filed. Patent pending. Available for licensing and/or research collaboration. For any business development and other collaborative partnerships, contact:  marketingbd@research.rutgers.edu
Patent Information:
Licensing Manager:
Ryan Escolin
Licensing Manager, Life Sciences
Rutgers, The State University of New Jersey
848-932-4566
nescolin@research.rutgers.edu
Business Development:
Eusebio Pires
Senior Manager, Technology Marketing & Business Development
Rutgers, The State University of New Jersey
ep620@research.rutgers.edu
Keywords: